2026 ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries
Grant supports LMIC researchers to run clinical trials repurposing existing therapies for high-burden unsolved diseases, with strong emphasis on community engagement.
Funder: Cures Within Reach
Due Dates (Anticipated): April 2027 (Letter of Intent deadline, projected)
Funding Amounts: Up to $70,000 per clinical trial, plus up to $8,500 additional for community engagement; project duration up to 36 months.
Summary: Supports underresourced LMIC researchers in conducting clinical trials repurposing existing therapies for unsolved diseases, emphasizing high-burden conditions and community engagement.
Key Information: For researchers in low/lower-middle income countries (LMICs) only; LOI required; all dates are projected—confirm on program page.
Description
This grant opportunity from Cures Within Reach is designed to support underresourced researchers and clinicians based in low and lower-middle income countries (LMICs), as defined by the World Bank, to conduct clinical trials that repurpose existing therapies for unsolved diseases. The program aims to build local research capacity and improve patient outcomes by enabling LMIC researchers to test generic, off-patent, or indigenous therapies—already approved for human use—in new indications that are not yet standard of care. The initiative strongly encourages projects addressing high disease burdens, such as non-communicable diseases, communicable diseases, maternal, neonatal, nutritional diseases, or injuries. All projects must include meaningful community engagement plans that go beyond patient recruitment, involving collaborations with community organizations, leaders, or patient groups.
